✦ LIBER ✦

Effects of pegylated interferon α-2a on hepatitis-C-virus-associated glomerulonephritis

✍ Scribed by Tokio Sugiura; Takuji Yamada; Yuri Kimpara; Naoya Fujita; Kenji Goto; Norihisa Koyama

Publisher: Springer
Year: 2009
Tongue: English
Weight: 234 KB
Volume: 24
Category: Article
ISSN: 0931-041X
DOI: 10.1007/s00467-008-0948-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon treatment on glomerulonephrit

Interferon treatment on glomerulonephritis associated with hepatitis C virus

✍ Sayuri Matsumoto; S. Nakajima; Kana Nakamura; Yuri Etani; Haruhiko Hirai; Nobuhi 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 58 KB

Randomized trial comparing pegylated int

Randomized trial comparing pegylated interferon α-2b versus pegylated interferon α-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

✍ Montserrat Laguno; Carmen Cifuentes; Javier Murillas; Sergio Veloso; Maria Larro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB

Pegylated interferon α therapy in acute

Pegylated interferon α therapy in acute hepatitis C: Relation to hepatitis C virus–specific T cell response kinetics

✍ Sanaa M. Kamal; Alaa Ismail; Camilla S. Graham; Qi He; Jens W. Rasenack; Thomas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

Pegylated interferon ␣ (PEG IFN-␣) improves sustained virological response rates in chronic hepatitis C, but neither its role in acute hepatitis C nor the biologic basis for its action has been defined. This prospective study assessed the efficacy of PEG IFN-␣ treatment in acute hepatitis C in relat

Treatment of hepatitis C in hemodialysis

Treatment of hepatitis C in hemodialysis patients using pegylated interferon α-2a in Turkey

✍ Sukran Kose; Alp Gurkan; Fatih Akman; Mehmet Kelesoglu; Ufuk Uner 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 197 KB

A case of deep venous thrombosis associa

A case of deep venous thrombosis associated with pegylated interferon α2b plus ribavirin treatment of chronic hepatitis C

✍ Chiaki Okuse; Kayo Adachi; Yoshiki Katakura; Kotaro Matsunaga; Toshiya Ishii; No 📂 Article 📅 2007 🏛 Springer Japan 🌐 English ⚖ 394 KB

“Real-Life” comparison of pegylated-inte

“Real-Life” comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus

✍ Julian Schulze zur Wiesch; Neele Pudelski; Lena Hoepner; Michael Supplieth; Pete 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6